Background
HIV persistence is enabled by immune evasion that reshapes host immune signaling. Epigenetic modifications, such as DNA methylation, represent an evasion strategy by modulating both proviral and host gene expression at diverse immunoregulatory sites. Interferon Gamma is a major early-response antiviral cytokine, whose expression is tightly controlled by promoter DNA methylation. Accordingly, we investigated whether HIV infection impacts epigenetic remodeling the IFNG promoter, offering insight into the molecular mechanisms that enable viral persistence.
Methods
To explore whether HIV viremia tracks with epigenetic modifications to impact IFNG expression, we assessed DNA methylation in the IFNG promoter of peripheral blood mononuclear cells from people with HIV (PWH). PBMCs from participants enrolled in the San Diego Primary Infection Resource Consortium (PIRC) were grouped by high (HIV RNA > 5000 copies), medium (500 to 4999 copies), and undetectable (≤ 50 copies) plasma viral loads (VL). Bisulfite sequencing was used to assess differential DNA methylation across all five CpG sites in the IFNG promoter, and corresponding IFNG transcriptional changes were determined with RT-qPCR.
Results
Participants included cisgender men (n=46) and a subset of cisgender women (n=3) with a median age of 34 (27, 46). Demographics were Non-Hispanic Caucasian (n=33), Black (n=3), other racial minorities (n=4), and Hispanic (n=9) participants. Those with undetectable VL were on antiretroviral therapy (ART), while most participants with medium and high VL were not on ART. Elevated plasma VL corresponded with significant decreases in DNA methylation in the IFNG promoter. PBMCs from medium VL participants had an average 7.14% decrease in methylation (range 5.3-10.6, p < 10-5), while high VL participants averaged a 22.44% decrease (range 22.1-23.0, p < 10-5) across all CpG sites compared to suppressed participants. High VL participants also exhibited elevation in IFNG mRNA compared to medium (p=0.012) and undetectable (p=0.0072) VL. This effect was intensified with normalization of IFNG mRNA to the T cell marker TCF7 (Figure 1).
Conclusions
Plasma HIV RNA correlates with epigenetic changes to the IFNG promoter, with consequential changes to transcriptional control of this cytokine. These results provide novel insights into the molecular host-pathogen interactions that allow HIV to leverage epigenetic machinery to tune early host antiviral immune response pathways.
Table or Figure
